Neoantigens Market Scope, Growth, Size and Share by 2028
Neoantigens Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 271.43 Million |
Market Size by 2028 | US$ 1,054.78 Million |
Global CAGR (2023 - 2028) | 31.2% |
Historical Data | 2021-2022 |
Forecast period | 2024-2028 |
Segments Covered |
By Treatment
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
By Treatment
- Combination Therapy
- Mono Therapy
By Therapeutic Specialty
- Gastrointestinal Cancer
- Lung Cancer
- Solid Tumors
- Urinary System Cancers
- Melanoma
- Head and Neck Cancer
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Achilles Therapeutics plc
- Advaxis, Inc.
- Frame Cancer Therapeutics
- Genocea, Gradalis, Inc.
- Gritstone Oncology
- Immunicum AB
- Medigene AG
- Ziopharm Oncology, Inc.
- Moderna, Inc.